Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U54CA267730 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
This study aims to characterize key mechanisms underlying the development, maintenance, and treatment of severe irritability in a clinically heterogeneous sample of school-aged youth.
Severe irritability in youth is associated with significant functional impairment and occurs across diagnostic categories. This study aims to characterize key mechanisms underlying the development, maintenance, and treatment of severe irritability in a clinically heterogeneous sample of school-aged youth. Participants will complete (a) a comprehensive, multimodal assessment - including diagnostic interviews, multi-informant behavioral ratings, and neurophysiological tasks - to evaluate core cognitive, behavioral, and psychosocial factors, and (b) evidence-based treatment (e.g., cognitive behavioral therapy). Repeated assessments throughout the study period will be used to evaluate study outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Treatment Group | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cognitive Behavioral Therapy | Behavioral | Participants will receive evidence-based treatment designed to address a wide range of emotional disorders. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Clinical Global Impressions - Improvement Scale | Clinician-rated assessment of overall clinical change, with scores ranging from 1 (very much improved) to 7 (very much worse). | Post-treatment (up to 28 weeks from baseline) |
| Affective Reactivity Index | Youth- and caregiver-reported measure of irritability, with total scores ranging from 0 to 12; higher scores indicate greater symptom severity. | Baseline to post-treatment (up to 28 weeks) |
| Measure | Description | Time Frame |
|---|---|---|
| Behavior Assessment System for Children | Youth- and caregiver-reported measure of behavioral and emotional functioning; T-scores of 70 or higher indicate clinically significant symptoms. | Baseline to post-treatment (up to 28 weeks) |
| Stop-Signal |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Sherelle Harmon, PhD | Contact | 18506458724 | harmonylab@psy.fsu.edu |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Florida State University | Recruiting | Tallahassee | Florida | 32304 | United States |
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| D001008 | Anxiety Disorders |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D015928 | Cognitive Behavioral Therapy |
| ID | Term |
|---|---|
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
Not provided
Not provided
Standard evidence-based intervention based on child's primary diagnosis.
Not provided
Not provided
Not provided
Not provided
Computerized task assessing inhibitory control in youth participants; longer stop-signal reaction times reflect slower inhibitory control.
| Baseline to post-treatment (up to 28 weeks) |
| Global-Local | Computerized task assessing set-shifting in youth participants; longer reaction times indicate poorer performance. | Baseline to post-treatment (up to 28 weeks) |
| Letter Updating | Computerized task assessing working memory updating in youth participants; higher scores indicate better updating abilities. | Baseline to post-treatment (up to 28 weeks) |